Lumen Specialty Pharmacy On track
Specialty pharmacy · Minority equity · $19.5M deployed · Last report Oct 5
Overview
What changed this month
- Cash rose $0.3M to $6.8M, far above the $2.0M minimum. The lowest point ahead is $7.0M in mid-November.
- Earnings are 5.2% above budget. Two new payer contracts added volume in oncology.
- Prescriptions filled rose 6% over last quarter and reimbursement days fell to 28.
Ending cash across operating accounts at the last weekly close.
$6.8M
Prior $6.5M · +$0.3M
On trackWeekly · as of Nov 6
Last 12 months’ EBITDA after approved adjustments, monthly.
$11.4M
Prior $11.1M · +2.7%
On trackMonthly · as of Sep 30
Debt service coverage: cash available for debt service ÷ interest and principal due. Higher is safer.
1.88x
Prior 1.85x · +0.03x · min 1.20x
On trackMonthly · as of Sep 30
Weeks of cash at the last 4 weeks’ average burn. New, added by Your Cohort
34 wks
Prior 33 wks · +1 wks
On trackWeekly · as of Nov 6
Days sales outstanding: how many days customers take to pay on average, last 3 months. Lower is better. New, added by Your Cohort
38 d
Prior 39 d · −1 d · target 45 d
On trackMonthly · as of Sep 30
(Revenue − cost of goods) ÷ revenue, last 12 months. New, added by Your Cohort
22.5%
Prior 22.2% · +0.3 pts
On trackMonthly · as of Sep 30
Cash, next 13 weeks
Ending cash by week · updated Tuesdays
ActualForecastCash low pointMinimum cash $2M2 weeks of spending $2.4M
| Week ending | Ending cash | Type | Against the lines |
|---|---|---|---|
| Oct 30 | $6.5M | Actual | Clear |
| Nov 6 | $6.8M | Actual | Clear |
| Nov 13 | $7M | Forecast · lowest | Clear |
| Nov 20 | $7.2M | Forecast | Clear |
| Nov 27 | $7.1M | Forecast | Clear |
| Dec 4 | $7.4M | Forecast | Clear |
| Dec 11 | $7.6M | Forecast | Clear |
| Dec 18 | $7.5M | Forecast | Clear |
| Dec 25 | $7.8M | Forecast | Clear |
| Jan 1 | $8M | Forecast | Clear |
| Jan 8 | $7.9M | Forecast | Clear |
| Jan 15 | $8.2M | Forecast | Clear |
| Jan 22 | $8.4M | Forecast | Clear |
- Next week in
- $1.7M
- Next week out
- $1.5M
- Net cash flow
- +$0.2M
- Ending cash, Nov 13
- $7.0M
- Cash low point
- $7M · Nov 13
- Last week, plan vs actual
- $6.6M → $6.8M
- Forecast accuracy, 4 wks
- 98.9%
- Invoices 90+ days late
- $0.1M
Decisions for you
Checked against the deal documents before they reach you
Nothing waiting. Requests from the company appear here after the contract check.
Covenants
All 4 passing · Q3 certificate due Nov 14
Net debt ÷ adjusted EBITDA, last 12 months. Lower is safer.31.1% room
Debt service coverage: cash available for debt service ÷ interest and principal due. Higher is safer.56.7% room
Equipment and other capital spending this fiscal year, against the yearly cap.44% room
Ending cash must stay at or above this amount every week.240% room
New marks a measure Your Cohort adds to Thorne’s reporting · fictional companies and figures · thresholds are placeholders · select or hover any dotted label for its definition
